SESSION TITLE: Fellows Procedures Posters SESSION TYPE: Fellow Case Report Posters PRESENTED ON: October 18-21, 2020 INTRODUCTION: The differential diagnosis for tracheal tumors is broad and often requires direct endobronchial evaluation for management. Neoplastic tumors account for 10% of tracheal masses. Herein, we describe a rare adult tracheal tumor that was successfully treated bronchoscopically. CASE PRESENTATION: A 48 year-old non-smoking female with childhood asthma presented to pulmonary clinic with a chronic cough for 4 months despite multiple courses of antibiotics and steroid bursts for suspected bronchitis. Due to persistent symptoms, she ultimately underwent a computed tomography scan of the chest which revealed a 0.9x0.6x0.5 cm polypoid-like density at the tracheal carina. Initial endobronchial biopsies showed inflammatory cells without evidence of malignancy. Due to concern for sampling artifact, she underwent a flexible/rigid bronchoscopy with tumor excision by snare electrocautery, argon plasma coagulation, and cryotherapy. Pathologic examination revealed an inflammatory myofibroblastic tumor (IMT) without an ALK rearrangement. A tumor board recommended curative tracheal resection versus surveillance bronchoscopy and imaging. The patient opted for surveillance as her symptoms had resolved. She has had annual bronchoscopies without any evidence of recurrence, and she remains asymptomatic. DISCUSSION: IMTs are slow growing quasi-neoplastic lesions that mostly affect children under 16 years old and are rarely reported in adults, accounting for 0.04-0.07% of all lung neoplasms. Most commonly affecting the lungs, these tumors can also involve a multitude of different organs. The etiology remains unknown although it is theorized to arise from an inflammatory process like a prior infection, trauma or surgery. However, the ALK rearrangement, which has been noted in 50% of IMTs, suggests a possible neoplastic origin. Classic pathologic features include myxoid spindle myofibroblasts with abundant inflammatory cells of plasma cells, lymphocytes, and eosinophils. Up to 80% of patients are asymptomatic but few may present with symptoms suggestive of, and commonly mistaken for, asthma. IMT treatment typically requires surgical resection via thorascoscopy or thoractomy. Chemotherapy, ALK directed therapies, and/or steroids have been used in nonsurgical cases. Few case reports have described effective bronchoscopic resection. A case series of 7 patients reported successful resection with one recurrence. Unfortunately, due to the tumor’s rarity, no robust studies exist for evaluating bronchoscopic treatment. A bronchoscopic approach offers a minimally invasive and potentially curative option but requires regular follow up for recurrence. CONCLUSIONS: IMTs are rare adult tracheal tumors, and treatment often entails surgical tracheal resection, which carries significant peri-operative risks with prolonged recovery. This case of IMT was successfully treated by bronchoscopic resection with curative effect. Reference #1: Jain S, Chopra P, Agarwal A, et al. Inflammatory myofibroblastic tumor of trachea. J Bronchol Intervent Pulmonol 2013;20:80-83. Reference #2: Oztuna F, Pehlivanlar M, Abul Y, et al. Adult inflammatory myofibroblastic tumor of the trachea: case report and literature review. Respir Care 2013;58:e72-6. DISCLOSURES: Speaker/Speaker's Bureau relationship with Boehringer-Ingelheim Pharmaceuticals Please note: $5001 - $20000 Added 04/07/2020 by Jaime Betancourt, source=Web Response, value=Honoraria Speaker/Speaker's Bureau relationship with Vapotherm, Inc Please note: $5001 - $20000 Added 04/07/2020 by Jaime Betancourt, source=Web Response, value=Honoraria No relevant relationships by Tao He, source=Web Response No relevant relationships by Leeyen Hsu, source=Web Response No relevant relationships by Scott Oh, source=Web Response
Read full abstract